Match Document Document Title
US20150071879 Stabilization of Aqueous Compositions of Proteins with Displacement Buffers  
An aqueous composition having increased protein stability is obtained by: a. determining a pH at which the protein has stability at the desired temperature; b. adding to the composition at least...
US20150164880 TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD  
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the...
US20140105850 TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD  
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the...
US20130272996 TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD  
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the...
US20100322900 Treatment of multiple sclerosis with laquinimod  
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the...
US20130280213 ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES  
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including:...
US20130129670 MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS  
The present invention relates to Macrophage Activating Factors such as GcMAF and compositions thereof, for use in the treatment of a patient suffering from CFS/ME and/or XMRV infection.
US20120100102 CANCER VACCINE  
We disclose a vaccine comprising a pappalysin and vaccine compositions comprising a pappalysin.
US20130195794 CANCER VACCINE  
The disclosure relates to a vaccine including at least one adjuvant useful in the prevention and treatment of blood cancers, for example lymphoma, leukaemia or myeloma.
US20120225029 Skin Cream  
The present invention relates to skin care compositions, including cosmeceuticals, for topical application, and more particularly, a skin cream, comprising cell culture medium conditioned by cells...
US20140086872 Methods of Treating a Subject for a Condition  
Methods are provided for treating a subject for at least one condition that includes inflammation, a blood clotting condition and autonomic nervous system dysfunction such as adrenergia, e.g.,...
US20110212136 Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury  
A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC (cABC) or a functional derivative of cABC to treat acute and chronic...
US20130295043 VACCINATION IN ELDERLY PATIENTS  
The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in an elderly patient preferably exhibiting an age of at...
US20140056848 Method for the Treatment of Multiple Sclerosis  
A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to...
US20150246061 VITAMIN D ANALOGUES FOR THE TREATMENT OF A NEUROLOGICAL DISORDER  
Disclosed herein are methods that use a vitamin D analogue to treat a neurological disorder. Additionally, pharmaceutical compositions comprising a vitamin D analogue and a neurotherapeutic agent...
US20120076837 SURFACE ENGINEERING OF TISSUE GRAFT MATERIALS FOR ENHANCED POROSITY AND CELL ADHESION  
In one aspect, the invention relates to providing enhanced application tissue graft materials in regenerative medicine through improved cellular interactions. Biocompatible implant materials,...
US20130209401 COMPOSITIONS AND METHODS FOR INHIBITING ENTRY OF A HEPATIC VIRUS  
The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection.
US20110171177 Compositions and Methods for Inhibiting Entry of a Hepatic Virus  
The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection.
US20120237479 METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN  
The present invention provides a method for treating multiple sclerosis (MS), and for reducing flu-like symptoms associated with administration of an interferon to a patient with MS. The method...
US20110059045 PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT  
The invention relates to therapeutic compositions for the treatment of cancer and, more specifically, compositions containing an agonist ligand for receptor 4-1BB and a type-1 interferon, the...
US20150056281 Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta  
This invention provides a method of treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the patient laquinimod as an...
US20130028866 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND INTERFERON-BETA  
This invention provides a method of treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the patient laquinimod as an...
US20110104107 COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION  
Methods and kits for preventing or reducing the likelihood of preeclampsia in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial...
US20120251439 Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis  
Specific binding members that bind the ED-A isoform of fibronectin for use in methods of diagnosis, detection, imaging and/or treatment of inflammatory bowel disease such as ulcerative colitis...
US20140065102 METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS  
It is disclosed a method for the treatment of HBV infection or HBV/HDV co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent...
US20120328567 BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF  
Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are...
US20110165122 METHOD FOR TARGETED AND SUSTAINED ANTIVIRAL THERAPY  
Compounds compositions and methods of modulating the immune response are provided. The method uses fusion proteins of a cytokine and an antibody to potentiate the action of the cytokine.
US20140056892 VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders  
The present invention relates to a fusion proteins comprising regulatory T cell protein, VISTA (V-domain Immunoglobulin Suppressor of T cell Activation (PD-L3) and an immunoglobulin protein (Ig)....
US20140369963 METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS  
It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first...
US20140369962 METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS  
It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first...
US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle  
Methods are provided for treating a subject for a condition. In accordance with the subject methods, at least a portion of a subject's autonomic nervous system is modulated during at least one...
US20110104106 COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION  
Methods and kits for preventing or reducing the likelihood of preterm labor in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial...
US20110177028 INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY  
Use of interferon-beta (IFN-β) and/or IFN-λ for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have...
US20110135596 FUSION PROTEIN COMPRISING UBIQUITIN OR UBIQUITIN-LIKE PROTEIN, MEMBRANE TRANSLOCATION SEQUENCE AND BIOLOGICALLY ACTIVE MOLECULE AND USE THEREOF  
A transmembrane fusion protein including ubiquitin or a ubiquitin-like protein, a membrane translocation sequence linked to the C-terminus of the ubiquitin or ubiquitin-like protein, and a...
US20110091421 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases  
The present invention discloses multiple treatment regimens for vascular-related diseases and disorders. The present invention provides for methods of treating vascular-related disorders based on...
US20120087859 NANOCARRIER HAVING ENHANCED SKIN PERMEABILITY, CELLULAR UPTAKE AND TUMOUR DELIVERY PROPERTIES  
The present invention relates to a biopolymer-modified nanocarrier in which chitosan is bound to a water-soluble biocompatible polymer that has been crosslinked via a photo-crosslinkable...
US20110097304 COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION  
Methods and kits for preventing or reducing the likelihood of spontaneous abortion in a recipient of artificial insemination are provided. The methods include administering into a recipient of...
US20110268699 METHODS FOR TREATING MULTIPLE SCLEROSIS USING TETRACYCLIC PYRAZINOINDOLES  
Methods and pharmaceutical compositions for treating multiple sclerosis are described. The methods and pharmaceutical compositions include a therapeutically effective amount of one or more...
US20110117181 TREATING HEPATITIS C VIRUS INFECTION WITH OVER-EXPRESSION OF MICRORNA-196  
The present invention is directed to methods of treating cells infected with HCV and mammals suffering from HCV infection by transfecting the infected cells with miRNA-196 mimic. miRNA-196 mimic...
US20100303760 TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS  
The invention relates to the use of INSP163 for treatment and/or prevention of cancer and/or musculoskeletal/connective tissue disorder, in particular of lung cancer and/or osteoarthritis....
US20110195049 COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS  
Described herein are compositions and methods for treating multiple sclerosis. In particular, described herein are compositions that include one or more dimebolins and/or pharmaceutically...
US20130089519 Method for Predicting a Therapy Response in Subjects with Multiple Sclerosis  
A method is provided for determining the efficacy of interferon-beta (IFN-β) therapy in a subject with multiple sclerosis. One step of the method can include obtaining a biological sample from the...
US20150125421 CYTOKINE-BASED FUSION PROTEINS FOR TREATMENT OF IMMUNE DISORDERS  
The present invention provides fusion proteins including an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine. Compositions and methods including the...
US20150110741 COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS  
Methods, systems and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis are disclosed.
US20100151009 FORMULATIONS FOR DELIVERING INSULIN  
Oral insulin formulations and processes for preparing oral insulin formulations are provided.
US20110091422 Use of Genetic Markers for Identifying the Response to Interferon Treatment in Multiple Sclerosis Patients  
The present invention relates to the use of genetic markers to identify the response to interferon-beta (IFN-beta) treatment in Multiple Sclerosis (MS) patients as well as a method for treating MS...
US20060024271 Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination  
A treatment or prophylaxis for viral infection using interferon (IFN) cytokines alone or in combination with ribavirin is provided. The treatments and prophylaxis allow for lowered dosages of...
US20080075696 Treatment Of Hepatitis C In The Asian Population With Interferon-Beta  
The invention relates to the use of IFN-beta in the manufacture of a medicament for the treatment of an HCV infection in a treatment-naïve patient belonging to the Asian population.
US20150139935 SLEEP APNEA TREATMENT  
Provided herein is technology relating to treating sleep apnea and particularly, but not exclusively, to treating sleep apnea with immunotherapeutics and/or anti-inflammatory drugs such as...
US20110097306 ORAL FORMULATIONS OF CLADRIBINE  
Provided are compositions of cladribine and cyclodextrin which are especially suited for the oral administration of cladribine.